文献速递物质与行为成瘾

新型小分子PKCε抑制剂减少小鼠乙醇摄入

Novel Small-Molecule Inhibitors of Protein Kinase C Epsilon Reduce Ethanol Consumption in Mice.
PubMed 文献 · Biol Psychiatry · 2017-12-02

该研究基于ROCK抑制剂Y-27632设计新型PKCε小分子抑制剂,体外筛选出Ki<20 nM的高效选择性化合物,并在小鼠中验证其可穿透血脑屏障、阻断乙醇刺激的GABA释放,腹腔注射40 mg/kg可减少野生型而非Prkce-/-小鼠的乙醇摄入。

要点

  • 两种化合物抑制PKCε的Ki<20 nM,且对PKCε的选择性优于其他激酶。
  • 40 mg/kg腹腔注射减少野生型小鼠乙醇摄入,Prkce-/-小鼠无效。
  • 一种化合物选择性减少乙醇摄入,另一种同时减少蔗糖和糖精摄入。

核心结论

  • 小分子PKCε抑制剂可减少小鼠乙醇摄入,支持其作为酒精使用障碍候选药物的开发方向。

研究设计与样本

  • 基于ROCK抑制剂Y-27632设计新型PKCε抑制剂,用体外激酶和结合实验筛选最有效化合物。
  • 在小鼠中研究化合物对乙醇刺激的突触传递、乙醇/蔗糖/奎宁摄入、乙醇诱导翻正反射丧失及乙醇清除的影响。

主要发现

  • 鉴定出两种化合物抑制PKCε的Ki<20 nM,对PKCε的选择性优于其他激酶,可穿过血脑屏障并在小鼠脑内达到有效浓度。
  • 化合物阻止中央杏仁核中乙醇刺激的γ-氨基丁酸释放。
  • 40 mg/kg腹腔注射减少野生型小鼠乙醇摄入,但在Prkce-/-小鼠中无效。
  • 一种化合物同时减少蔗糖和糖精摄入,另一种对乙醇具有选择性。
  • 两种化合物均通过脱靶效应短暂损害运动,但不干扰减少乙醇摄入的能力;一种化合物延长乙醇诱导翻正反射丧失的恢复,但该效应在Prkce-/-小鼠中同样存在,属脱靶效应;两者均不改变乙醇清除。

关键数值与推荐

  • 化合物抑制PKCε的Ki<20 nM。
  • 化合物腹腔注射剂量为40 mg/kg。

临床怎么用

  • 提示PKCε小分子抑制剂可作为减少酒精消费的潜在药物先导化合物,但需进一步临床前和临床研究验证。

局限性

  • 研究仅在小鼠中进行,尚未在人类中验证疗效和安全性。
  • 化合物存在脱靶效应,如短暂运动损害和延长乙醇诱导翻正反射丧失恢复。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite the high cost and widespread prevalence of alcohol use disorders, treatment options are limited, underscoring the need for new, effective medications. Previous results using protein kinase C epsilon (PKCε) knockout mice, RNA interference against PKCε, and peptide inhibitors of PKCε predict that small-molecule inhibitors of PKCε should reduce alcohol consumption in humans. METHODS: We designed a new class of PKCε inhibitors based on the Rho-associated protein kinase (ROCK) inhibitor Y-27632. In vitro kinase and binding assays were used to identify the most potent compounds. Their effects on ethanol-stimulated synaptic transmission; ethanol, sucrose, and quinine consumption; ethanol-induced loss of righting; and ethanol clearance were studied in mice. RESULTS: We identified two compounds that inhibited PKCε with Ki <20 nM, showed selectivity for PKCε over other kinases, crossed the blood-brain barrier, achieved effective concentrations in mouse brain, prevented ethanol-stimulated gamma-aminobutyric acid release in the central amygdala, and reduced ethanol consumption when administered intraperitoneally at 40 mg/kg in wild-type but not in Prkce-/- mice. One compound also reduced sucrose and saccharin consumption, while the other was selective for ethanol. Both transiently impaired locomotion through an off-target effect that did not interfere with their ability to reduce ethanol intake. One compound prolonged recovery from ethanol-induced loss of righting but this was also due to an off-target effect since it was present in Prkce-/- mice. Neither altered ethanol clearance. CONCLUSIONS: These results identify lead compounds for development of PKCε inhibitors that reduce alcohol consumption.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Blasio A, Wang J, Wang D, et al. Novel Small-Molecule Inhibitors of Protein Kinase C Epsilon Reduce Ethanol Consumption in Mice. Biol Psychiatry. 2017. PMID: 29198469. doi:10.1016/j.biopsych.2017.10.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。